DK1074542T3 - Sulfonamidholdige indolforbindelser - Google Patents
Sulfonamidholdige indolforbindelserInfo
- Publication number
- DK1074542T3 DK1074542T3 DK00905321T DK00905321T DK1074542T3 DK 1074542 T3 DK1074542 T3 DK 1074542T3 DK 00905321 T DK00905321 T DK 00905321T DK 00905321 T DK00905321 T DK 00905321T DK 1074542 T3 DK1074542 T3 DK 1074542T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- ring
- represents hydrogen
- indole compounds
- cyanophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11049870A JP2000247949A (ja) | 1999-02-26 | 1999-02-26 | スルホンアミド含有インドール化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1074542T3 true DK1074542T3 (da) | 2006-08-14 |
Family
ID=12843091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00905321T DK1074542T3 (da) | 1999-02-26 | 2000-02-24 | Sulfonamidholdige indolforbindelser |
Country Status (17)
Country | Link |
---|---|
US (3) | US6469043B1 (da) |
EP (1) | EP1074542B1 (da) |
JP (3) | JP2000247949A (da) |
KR (1) | KR100627611B1 (da) |
CN (1) | CN1132814C (da) |
AT (1) | ATE325094T1 (da) |
AU (1) | AU766936B2 (da) |
CA (1) | CA2327253C (da) |
DE (1) | DE60027648T2 (da) |
DK (1) | DK1074542T3 (da) |
ES (1) | ES2259997T3 (da) |
HU (1) | HU228787B1 (da) |
NO (1) | NO317299B1 (da) |
NZ (1) | NZ507464A (da) |
PT (1) | PT1074542E (da) |
RU (1) | RU2208607C2 (da) |
WO (1) | WO2000050395A1 (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60141889D1 (de) * | 2000-02-03 | 2010-06-02 | Eisai R&D Man Co Ltd | Inhibitoren der integrinexpression |
JP2004508303A (ja) * | 2000-08-30 | 2004-03-18 | プライムサイト,インコーポレイティド | 抗腫瘍療法 |
TWI283575B (en) | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
CA2438427C (en) * | 2001-02-21 | 2011-04-12 | Eisai Co., Ltd. | Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
EP1433479B8 (en) * | 2001-09-05 | 2008-01-23 | Eisai R&D Management Co., Ltd. | Appetite-stimulating agents and remedies for anorexia |
JPWO2003022271A1 (ja) * | 2001-09-05 | 2004-12-24 | エーザイ株式会社 | リンパ球活性化抑制剤および自己免疫疾患治療剤 |
WO2003074045A1 (fr) * | 2002-03-05 | 2003-09-12 | Eisai Co., Ltd. | Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese |
US7943800B2 (en) | 2003-03-28 | 2011-05-17 | Sloan-Kettering Institute For Cancer Research | Migrastatin analogs and uses thereof |
WO2004091664A1 (ja) * | 2003-04-18 | 2004-10-28 | Eisai Co., Ltd. | 細胞質リンゴ酸脱水素酵素阻害剤 |
US20070037854A1 (en) * | 2003-09-10 | 2007-02-15 | Kenji Hayashi | Process for preparing sulfonamide-containing indole compounds |
EP1666463B1 (en) * | 2003-09-10 | 2010-11-03 | Eisai R&D Management Co., Ltd. | Crystal of sulfonamide-containing indole compound and process for producing the same |
WO2005048938A2 (en) * | 2003-11-13 | 2005-06-02 | California Pacific Medical Center | Anti-pecam therapy for metastasis suppression |
US8957056B2 (en) * | 2004-05-25 | 2015-02-17 | Sloan-Kettering Instiute For Cancer Research | Migrastatin analogs in the treatment of cancer |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
EP2364699A1 (en) | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Joint use of sulfonamide based compound with angiogenesis inhibitor |
WO2006034478A2 (en) * | 2004-09-23 | 2006-03-30 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
PL1859793T3 (pl) | 2005-02-28 | 2011-09-30 | Eisai R&D Man Co Ltd | Nowe połączone zastosowanie związku sulfonamidowego w leczeniu choroby nowotworowej |
EP2308839B1 (en) * | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
AU2006318212C1 (en) * | 2005-11-23 | 2012-08-30 | The Board Of Regents Of The University Of Texas System | Oncogenic ras-specific cytotoxic compound and methods of use thereof |
US7625896B2 (en) * | 2005-11-25 | 2009-12-01 | Hoffman-La Roche Inc. | Pyridylsulfonamide derivatives |
WO2007086605A1 (ja) * | 2006-01-27 | 2007-08-02 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の効果を予測する方法 |
US20100291592A1 (en) | 2006-04-20 | 2010-11-18 | Taro Semba | Novel marker for sensitivity against sulfonamide compound |
DE102007012284A1 (de) * | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
JP2012136435A (ja) * | 2009-03-30 | 2012-07-19 | Eisai R & D Management Co Ltd | 腫瘍組織の感受性を検査する方法 |
KR102083041B1 (ko) | 2012-02-22 | 2020-05-27 | 샌포드 번햄 프레비즈 메디컬 디스커버리 인스티튜트 | 술폰아미드 화합물 및 tnap 억제제로서 용도 |
CN104098498A (zh) * | 2014-07-30 | 2014-10-15 | 天津市斯芬克司药物研发有限公司 | 一种吲唑类化合物及其制备方法 |
CN111601805A (zh) * | 2017-11-27 | 2020-08-28 | 科学和工业研究协会 | 作为选择性hdac抑制剂的吲哚(氨磺酰基)n-羟基苯甲酰胺衍生物 |
JP2021511290A (ja) * | 2018-01-25 | 2021-05-06 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | タンパク質分解のためのスルホンアミド誘導体 |
WO2020210139A1 (en) * | 2019-04-10 | 2020-10-15 | Peloton Therapeutics, Inc. | Pyrazolesulfonamides as antitumor agents |
WO2024039689A1 (en) * | 2022-08-15 | 2024-02-22 | Recursion Pharmaceuticals, Inc. | Heterocycle rbm39 modulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9115160D0 (en) * | 1991-07-12 | 1991-08-28 | Erba Carlo Spa | Methylen-oxindole derivatives and process for their preparation |
JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
AU683492B2 (en) | 1993-09-10 | 1997-11-13 | Eisai R&D Management Co., Ltd. | Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
JP3690831B2 (ja) | 1995-02-27 | 2005-08-31 | エーザイ株式会社 | インドール含有スルホンアミド誘導体 |
JP4130700B2 (ja) * | 1996-02-26 | 2008-08-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗腫瘍剤含有組成物 |
JP3868534B2 (ja) * | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
DE60141889D1 (de) * | 2000-02-03 | 2010-06-02 | Eisai R&D Man Co Ltd | Inhibitoren der integrinexpression |
-
1999
- 1999-02-26 JP JP11049870A patent/JP2000247949A/ja active Pending
-
2000
- 2000-02-24 AU AU26916/00A patent/AU766936B2/en not_active Ceased
- 2000-02-24 US US09/647,215 patent/US6469043B1/en not_active Expired - Lifetime
- 2000-02-24 DK DK00905321T patent/DK1074542T3/da active
- 2000-02-24 DE DE60027648T patent/DE60027648T2/de not_active Expired - Lifetime
- 2000-02-24 PT PT00905321T patent/PT1074542E/pt unknown
- 2000-02-24 HU HU0101434A patent/HU228787B1/hu not_active IP Right Cessation
- 2000-02-24 RU RU2000129508/04A patent/RU2208607C2/ru not_active IP Right Cessation
- 2000-02-24 WO PCT/JP2000/001071 patent/WO2000050395A1/ja active IP Right Grant
- 2000-02-24 JP JP2000600978A patent/JP3866041B2/ja not_active Expired - Fee Related
- 2000-02-24 NZ NZ507464A patent/NZ507464A/en not_active IP Right Cessation
- 2000-02-24 EP EP00905321A patent/EP1074542B1/en not_active Expired - Lifetime
- 2000-02-24 ES ES00905321T patent/ES2259997T3/es not_active Expired - Lifetime
- 2000-02-24 KR KR1020007011026A patent/KR100627611B1/ko not_active IP Right Cessation
- 2000-02-24 AT AT00905321T patent/ATE325094T1/de active
- 2000-02-24 CA CA002327253A patent/CA2327253C/en not_active Expired - Fee Related
- 2000-02-24 CN CN008002290A patent/CN1132814C/zh not_active Expired - Fee Related
- 2000-10-24 NO NO20005357A patent/NO317299B1/no not_active IP Right Cessation
-
2002
- 2002-03-18 US US10/098,421 patent/US6638964B2/en not_active Expired - Lifetime
- 2002-03-18 US US10/098,420 patent/US6673787B2/en not_active Expired - Lifetime
-
2010
- 2010-04-02 JP JP2010085696A patent/JP2010180229A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR100627611B1 (ko) | 2006-09-25 |
ES2259997T3 (es) | 2006-11-01 |
JP2010180229A (ja) | 2010-08-19 |
KR20010042434A (ko) | 2001-05-25 |
CA2327253A1 (en) | 2000-08-31 |
AU766936B2 (en) | 2003-10-23 |
PT1074542E (pt) | 2006-07-31 |
NO20005357L (no) | 2000-12-22 |
US6469043B1 (en) | 2002-10-22 |
RU2208607C2 (ru) | 2003-07-20 |
JP3866041B2 (ja) | 2007-01-10 |
CN1294579A (zh) | 2001-05-09 |
NO317299B1 (no) | 2004-10-04 |
EP1074542A1 (en) | 2001-02-07 |
US6673787B2 (en) | 2004-01-06 |
EP1074542B1 (en) | 2006-05-03 |
DE60027648T2 (de) | 2007-04-05 |
WO2000050395A1 (fr) | 2000-08-31 |
HUP0101434A3 (en) | 2001-10-29 |
US20020128483A1 (en) | 2002-09-12 |
DE60027648D1 (de) | 2006-06-08 |
AU2691600A (en) | 2000-09-14 |
ATE325094T1 (de) | 2006-06-15 |
NZ507464A (en) | 2003-10-31 |
US6638964B2 (en) | 2003-10-28 |
JP2000247949A (ja) | 2000-09-12 |
HUP0101434A2 (hu) | 2001-09-28 |
US20020128480A1 (en) | 2002-09-12 |
CA2327253C (en) | 2007-10-16 |
EP1074542A4 (en) | 2002-02-06 |
NO20005357D0 (no) | 2000-10-24 |
CN1132814C (zh) | 2003-12-31 |
HU228787B1 (en) | 2013-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1074542T3 (da) | Sulfonamidholdige indolforbindelser | |
NZ514873A (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
ATE129714T1 (de) | Heterocyclische biphosphonsäurederivate. | |
NZ336302A (en) | Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia | |
DK0749424T3 (da) | Naphthalenderivater som prostaglandin-I2-agonister | |
DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
DE69609325T2 (de) | Derivate des radicicols | |
NO934536D0 (no) | Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler | |
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
CA2134077A1 (en) | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy | |
ATE233242T1 (de) | Chinoline und chinazoline verbindungen und ihre therapeutische anwendung | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
HUP9902270A1 (hu) | Analgetikus hatású akridinszármazékok, előállításuk és alkalmazásuk | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására | |
EP0254527A3 (en) | New tetracyclic indole derivatives | |
ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
ECSP993005A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos |